Abstract
The known classes of genes that function as tumor suppressors and oncogenes have recently been expanded to include the microRNA (miRNA) family of regulatory molecules. miRNAs negatively regulate the stability and translation of target messenger RNAs (mRNA) and have been implicated in diverse processes such as cellular differentiation, cell-cycle control and apoptosis. Examination of tumor-specific miRNA expression profiles has revealed widespread dysregulation of these molecules in diverse cancers. Although studies addressing their role in cancer pathogenesis are at an early stage, it is apparent that loss- or gain-of-function of specific miRNAs contributes to cellular transformation and tumorigenesis. The available evidence clearly demonstrates that these molecules are intertwined with cellular pathways regulated by classical oncogenes and tumor suppressors such as MYC, RAS and p53. Incorporation of miRNA regulation into current models of molecular cancer pathogenesis will be essential to achieve a complete understanding of this group of diseases.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alexandrow MG, Moses HL . (1997). Kips off to Myc: implications for TGF beta signaling. J Cell Biochem 66: 427–432.
Ambros V . (2004). The functions of animal microRNAs. Nature 431: 350–355.
Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R et al. (2005). Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122: 553–563.
Bartel DP . (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281–297.
Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O et al. (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766–770.
Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RH, Cuppen E . (2005). Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120: 21–24.
Bracken AP, Ciro M, Cocito A, Helin K . (2004). E2F target genes: unraveling the biology. Trends Biochem Sci 29: 409–417.
Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM . (2003). bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25–36.
Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002). Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524–15529.
Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al. (2005). A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353: 1793–1801.
Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD et al. (2004a). MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101: 11755–11760.
Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. (2004b). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999–3004.
Chan JA, Krichevsky AM, Kosik KS . (2005). MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029–6033.
Chen CY, Shyu AB . (1995). AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20: 465–470.
Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al. (2005). miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102: 13944–13949.
Cole MD, McMahon SB . (1999). The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 18: 2916–2924.
Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N et al. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E{micro}-miR. Proc Natl Acad Sci USA 103: 7024–7029.
Dang CV . (1999). c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19: 1–11.
Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L et al. (2000). Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343: 1910–1916.
Dong JT, Boyd JC, Frierson Jr HF . (2001). Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate 49: 166–171.
Du T, Zamore PD . (2005). microPrimer: the biogenesis and function of microRNA. Development 132: 4645–4652.
Eiriksdottir G, Johannesdottir G, Ingvarsson S, Bjornsdottir IB, Jonasson JG, Agnarsson BA et al. (1998). Mapping loss of heterozygosity at chromosome 13q: loss at 13q12-q13 is associated with breast tumour progression and poor prognosis. Eur J Cancer 34: 2076–2081.
Eis PS, Tam W, Sun L, Chadburn A, Li Z, Gomez MF et al. (2005). Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci USA 102: 3627–3632.
el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J et al. (2003). Genomic targets of the human c-Myc protein. Genes Dev 17: 1115–1129.
Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ . (2006). miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34: D140–D144.
Hatfield SD, Shcherbata HR, Fischer KA, Nakahara K, Carthew RW, Ruohola-Baker H . (2005). Stem cell division is regulated by the microRNA pathway. Nature 435: 974–978.
Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S et al. (2005). A polycistronic microRNA cluster, miR-17–92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628–9632.
He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S et al. (2005a). The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci USA 102: 19075–19080.
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al. (2005b). A microRNA polycistron as a potential human oncogene. Nature 435: 828–833.
Hemann MT, Fridman JS, Zilfou JT, Hernando E, Paddison PJ, Cordon-Cardo C et al. (2003). An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet 33: 396–400.
Hickman ES, Moroni MC, Helin K . (2002). The role of p53 and pRB in apoptosis and cancer. Curr Opin Genet Dev 12: 60–66.
Honda S, Tanaka-Kosugi C, Yamada S, Sano T, Matsumoto T, Itakura M et al. (2003). Human pituitary adenomas infrequently contain inactivation of retinoblastoma 1 gene and activation of cyclin dependent kinase 4 gene. Endocr J 50: 309–318.
Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065–7070.
Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J et al. (2005). Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120: 623–634.
John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS . (2004). Human MicroRNA targets. PLoS Biol 2: e363.
Johnson DG, Cress WD, Jakoi L, Nevins JR . (1994). Oncogenic capacity of the E2F1 gene. Proc Natl Acad Sci USA 91: 12823–12827.
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A et al. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635–647.
Kim VN . (2005). MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol.
Koo SH, Ihm CH, Kwon KC, Lee JS, Park JW, Kim JW . (2003). Microsatellite alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Cancer Genet Cytogenet 146: 139–144.
Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al. (2005). Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438: 685–689.
Lai EC . (2004). Predicting and validating microRNA targets. Genome Biol 5: 115.
Lee RC, Feinbaum RL, Ambros V . (1993). The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843–854.
Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR . (1997). Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature 387: 422–426.
Lewis BP, Burge CB, Bartel DP . (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15–20.
Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB . (2003). Prediction of mammalian microRNA targets. Cell 115: 787–798.
Li Y, Pei J, Xia H, Ke H, Wang H, Tao W . (2003). Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 22: 4398–4405.
Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J et al. (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769–773.
Lin YW, Sheu JC, Liu LY, Chen CH, Lee HS, Huang GT et al. (1999). Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions. Eur J Cancer 35: 1730–1734.
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834–838.
Malumbres M, Barbacid M . (2003). RAS oncogenes: the first 30 years. Nat Rev Cancer 3: 459–465.
Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, Elton TS . (2006). Microrna-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem.
Matsumura I, Tanaka H, Kanakura Y . (2003). E2F1 and c-Myc in cell growth and death. Cell Cycle 2: 333–338.
Michael MZ, SM OC, van Holst Pellekaan NG, Young GP, James RJ . (2003). Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882–891.
O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT . (2005). c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839–843.
Ota A, Tagawa H, Karnan S, Tsuzuki S, Karpas A, Kira S et al. (2004). Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res 64: 3087–3095.
Pajic A, Spitkovsky D, Christoph B, Kempkes B, Schuhmacher M, Staege MS et al. (2000). Cell cycle activation by c-myc in a Burkitt lymphoma model cell line. Int J Cancer 87: 787–793.
Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B et al. (2000). Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408: 86–89.
Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE et al. (2000). The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403: 901–906.
Richter J, Wagner U, Schraml P, Maurer R, Alund G, Knonagel H et al. (1999). Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 59: 5687–5691.
Sanchez-Beato M, Sanchez-Aguilera A, Piris MA . (2003). Cell cycle deregulation in B-cell lymphomas. Blood 101: 1220–1235.
Schiavone N, Rosini P, Quattrone A, Donnini M, Lapucci A, Citti L et al. (2000). A conserved AU-rich element in the 3′ untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis. FASEB J 14: 174–184.
Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88: 593–602.
Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M et al. (2004). Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432: 173–178.
Sulis ML, Parsons R . (2003). PTEN: from pathology to biology. Trends Cell Biol 13: 478–483.
Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H et al. (2004). Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753–3756.
Tam W, Ben-Yehuda D, Hayward WS . (1997). bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA. Mol Cell Biol 17: 1490–1502.
Tam W, Hughes SH, Hayward WS, Besmer P . (2002). Avian bic, a gene isolated from a common retroviral site in avian leukosis virus-induced lymphomas that encodes a noncoding RNA, cooperates with c-myc in lymphomagenesis and erythroleukemogenesis. J Virol 76: 4275–4286.
Ten Dijke P, Goumans MJ, Itoh F, Itoh S . (2002). Regulation of cell proliferation by Smad proteins. J Cell Physiol 191: 1–16.
Tsang YS, Lo KW, Leung SF, Choi PH, Fong Y, Lee JC et al. (1999). Two distinct regions of deletion on chromosome 13q in primary nasopharyngeal carcinoma. Int J Cancer 83: 305–308.
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257–2261.
Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R et al. (2006). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124: 1169–1181.
Weinberg RA . (1996). E2F and cell proliferation: a world turned upside down. Cell 85: 457–459.
Wightman B, Ha I, Ruvkun G . (1993). Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855–862.
Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K et al. (2005). Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 434: 338–345.
Xu P, Vernooy SY, Guo M, Hay BA . (2003). The Drosophila microRNA miR-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 13: 790–795.
Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ . (1996). Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85: 537–548.
Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189–198.
Acknowledgements
We thank Emily Gesner from the University of Alberta for helpful discussions in the early stages of writing. JTM is a March of Dimes Basil O’Connor Scholar, a Rita Allen Foundation Scholar, and also receives support from the Lustgarten Foundation for Pancreatic Cancer Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kent, O., Mendell, J. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 25, 6188–6196 (2006). https://doi.org/10.1038/sj.onc.1209913
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1209913
Keywords
This article is cited by
-
MiR-7-5p/KLF4 signaling inhibits stemness and radioresistance in colorectal cancer
Cell Death Discovery (2023)
-
Helicobacter pylori infection induces abnormal expression of pro-angiogenic gene ANGPT2 and miR-203a in AGS gastric cell line
Brazilian Journal of Microbiology (2023)
-
MiR-214-3p targets Ras-related protein 14 (RAB14) to inhibit cellular migration and invasion in esophageal Cancer cells
BMC Cancer (2022)
-
MicroRNA expression signature and target prediction in familial and sporadic primary macronodular adrenal hyperplasia (PMAH)
BMC Endocrine Disorders (2022)
-
Reduced miR-371b-5p expression drives tumor progression via CSDE1/RAC1 regulation in triple-negative breast cancer
Oncogene (2022)